Susan E Bates

24PUBLICATIONS
121CO-AUTHORS
Predictive and prognostic markersMolecular targetsChemotherapySolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 18, 2026
Impact of Beta Blockers, Statins, and Cholinergic Agents on Clinical Outcomes in Pancreatic Cancer: A Retrospective VA Cohort Study.

|Jun 12, 2026
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.

|Jan 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck

|Dec 30, 2025
CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma.

Luigi Brancato, Damar Osok, Laurent Van den Bossche

|May 31, 2025
A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgery.

Ruth A White, Valeria Mezzano-Robinson, Qiongyu Shi

|Jul 15, 2024
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma.

Maryam Safari, Luigi Scotto, Agnes Basseville

Pageof 4

Frequent Collaborators

3 joint publications

Maryam Safari

3 joint publications

Thomas Litman

2 joint publications

Ruth A White

2 joint publications

Gulam A Manji